2. Signaling Pathways
  3. Others
  4. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (10876):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W040329S3
    2'-Deoxyadenosine-15N5,d13
    2'-Deoxyadenosine-15N5,d13 is deuterium and 15N labeled 2'-Deoxyadenosine (HY-W040329). 2′-Deoxyadenosine is an adenine nucleoside that inhibits glucose-stimulated insulin release. 2′-Deoxyadenosine inhibits glucose-stimulated increases seen in islet cyclic AMP (cAMP) accumulation. 2'-Deoxyadenosine activates caspase-3 and promotes apoptosis. 2'-Deoxyadenosine inhibits the activity of S-adenosyl-L-homocysteine hydrolase (SAHH). 2'-Deoxyadenosine inhibits the growth of various cells. 2'-Deoxyadenosine has an anticancer effect on colon cancer.
    2'-Deoxyadenosine-<sup>15</sup>N<sub>5</sub>,d<sub>13</sub>
  • HY-I1029S
    L-Homophenylalanine-d4
    L-Homophenylalanine-d4 is the deuterium labeled L-Homophenylalanine (HY-I1029). L-Homophenylalanine is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
    L-Homophenylalanine-d<sub>4</sub>
  • HY-W740965
    Linolenic acid glycidyl ester-d5
    Linolenic acid glycidyl ester-d5 (9,12,15-Octadecatrienoic acid-d5; Glycidyl linolenate-d5) is the deuterium labeled Linolenic acid glycidyl ester (HY-W587910). Linolenic acid glycidyl ester (9,12,15-Octadecatrienoic acid; Glycidyl linolenate) is an ester product.
    Linolenic acid glycidyl ester-d<sub>5</sub>
  • HY-166894S
    3,3′,4,4′,5,5′-Hexabromo diphenyl ether-13C12
    3,3′,4,4′,5,5′-Hexabromo diphenyl ether-13C12 is 13C labeled 3,3′,4,4′,5,5′-Hexabromo diphenyl ether.
    3,3′,4,4′,5,5′-Hexabromo diphenyl ether-<sup>13</sup>C<sub>12</sub>
  • HY-111964S1
    Lenacapavir-d5
    Lenacapavir-d5 (GS-6207-d5) is the deuterium labeled Lenacapavir (HY-111964). Lenacapavir (GS-6207) is an HIV-1 capsid inhibitor. Lenacapavir binds to the interface between capsid hexamers and CA monomers, disrupts capsid assembly and viral maturation, inhibits nuclear translocation of HIV-1 DNA, interferes with CA-mediated protein-protein interactions, reduces the formation of 2-LTR circles and pre-integration proviruses, induces aberrant capsids, and decreases the production of mature HIV-1. Lenacapavir exhibits activity against a variety of HIV-1 subtypes and clinical isolates. Lenacapavir is applicable to research related to human immunodeficiency virus type 1 (HIV-1) infection.
    Lenacapavir-d<sub>5</sub>
  • HY-B1449S9
    Uridine-13C,15N2
    Uridine-13C,15N2 (β-Uridine-13C,15N2) is a 13C- and 15N-labeled Uridine (HY-B1449).
    Uridine-<sup>13</sup>C,<sup>15</sup>N<sub>2</sub>
  • HY-17507S
    Pantoprazole-d6
    Pantoprazole-d6 is deuterium labeled Pantoprazole. Pantoprazole (BY10232) is an orally active and potent proton pump inhibitor (PPI). Pantoprazole, a substituted benzimidazole, is a potent H+/K+-ATPase inhibitor with an IC50 of 6.8 μM. Pantoprazole improves pH stability and has anti-secretory, anti-ulcer activities. Pantoprazole significantly increased tumor growth delay combined with Doxorubicin (HY-15142).
    Pantoprazole-d<sub>6</sub>
  • HY-W011926S
    Diisopropyl phthalate-d4
    		98.8%
    Diisopropyl phthalate-d4 (DiPP-d4) is the deuterium labeled Diisopropyl Phthalate (HY-W011926). Diisopropyl phthalate (DiPP) is a phthalate diester, which is widely used as an additive in plastics and consumer products. Diisopropyl phthalate has a weak binding ability to the recombinant human estrogen receptor, with an IC50 of 41000 μM.
    Diisopropyl phthalate-d<sub>4</sub>
  • HY-B1282S
    Sulfaquinoxaline-d4
    Sulfaquinoxaline-d4 is the deuterium labeled Sulfaquinoxaline. Sulfaquinoxaline is an antimicrobial for veterinary use, with activity against a broad spectrum of Gram-negative and Gram-positive bacteria. Sulfaquinoxaline is used to prevent coccidiosis and bacterial infections.
    Sulfaquinoxaline-d<sub>4</sub>
  • HY-W722015
    1-(2,3-Dichloro-4-methoxyphenyl)-1-butanone-d7
    1-(2,3-Dichloro-4-methoxyphenyl)-1-butanone-d7 is the deuterium labeled 1-(2,3-Dichloro-4-methoxyphenyl)butan-1-one (HY-W716896).
    1-(2,3-Dichloro-4-methoxyphenyl)-1-butanone-d<sub>7</sub>
  • HY-17042AS
    Cetirizine-d4 dihydrochloride
    Cetirizine-d4 (dihydrochloride) is a deuterium labeled Cetirizine. Cetirizine, a second-generation antihistamine and the carboxylated metabolite of hydroxyzine, is a specific, orally active and long-acting histamine H1-receptor antagonist. Cetirizine marks antiallergic properties and inhibits eosinophil chemotaxis during the allergic response.
    Cetirizine-d<sub>4</sub> dihydrochloride
  • HY-166899S
    1,3-Dibromo-2,7,8-trichlorodibenzofuran-13C12
    1,3-Dibromo-2,7,8-trichlorodibenzofuran-13C12 is 13C labeled 1,3-Dibromo-2,7,8-trichlorodibenzofuran.
    1,3-Dibromo-2,7,8-trichlorodibenzofuran-<sup>13</sup>C<sub>12</sub>
  • HY-B0421S2
    Mycophenolic acid-13C17
    Mycophenolic acid-13C17 (Mycophenolate-13C17) is the 13C labeled Mycophenolic acid (HY-B0421). Mycophenolic acid is a potent uncompetitive inosine monophosphate dehydrogenase (IMPDH) inhibitor with an EC50 of 0.24 μM. Mycophenolic acid demonstrates antiviral effects against a wide range of RNA viruses including influenza. Mycophenolic acid is an immunosuppressive agent. Antiangiogenic and antitumor effects.
    Mycophenolic acid-<sup>13</sup>C<sub>17</sub>
  • HY-W766965
    3,5-Di-O-p-chlorobenzoyl a-Floxuridine-13C,15N2
    3,5-Di-O-p-chlorobenzoyl a-Floxuridine-13C,15N2 is the 13C- and 15N-labeled 3,5-Di-O-p-chlorobenzoyl a-Floxuridine.
    3,5-Di-O-p-chlorobenzoyl a-Floxuridine-13C,15N2
  • HY-N0229S7
    L-Alanine-2-13C
    L-Alanine-2-13C is the 13C-labeled L-Alanine. L-Alanine is a non-essential amino acid, involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and central nervous system.
    L-Alanine-2-<sup>13</sup>C
  • HY-141945S
    Taurochenodeoxycholic acid-3-o-glucuronide-d4 (disodium)
    Taurochenodeoxycholic acid-3-o-glucuronide-d4 (disodium) is the deuterium labeled Taurochenodeoxycholic acid-3-o-glucuronide.
    Taurochenodeoxycholic acid-3-o-glucuronide-d<sub>4</sub> (disodium)
  • HY-B1955S
    4',4-Dibromobiphenyl-d8
    4',4-Dibromobiphenyl-d8 is the deuterium labeled 4',4-Dibromobiphenyl[1].
    4',4-Dibromobiphenyl-d<sub>8</sub>
  • HY-W005541S1
    3-Ethylphenylboronic acid-d5
    3-Ethylphenylboronic acid-d5 (B-(3-Ethylphenyl)-Boronic acid-d5) is a deuterium labeled 3-Ethylphenylboronic acid.
    3-Ethylphenylboronic acid-d5
  • HY-77956S1
    Thyminose-13C-1
    Thyminose-13C-1 is the 13C labeled Thyminose. Thyminose is an endogenous metabolite.
    Thyminose-<sup>13</sup>C-1
  • HY-W747903
    Metazachlor Oxalic Acid-d6
    Metazachlor Oxalic Acid-d6 is the deuterium labeled Metazachlor Oxalic Acid (HY-W746555).
    Metazachlor Oxalic Acid-d<sub>6</sub>